Search research articles
Contact Us
Filters
Showing results (151-160 of 274) with videos related to
Page
of 28
Sort By:
Oncology Reports
|
November 21, 2008
EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells
Min K Baek, Mi H Kim, Hee J Jang, et al.
International Journal of Obesity (2005)
|
April 17, 2008
Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase
E-H Jang, J-S Moon, J H Ko, et al.
Fundamental & Clinical Pharmacology
|
October 30, 1998
Effect of rebamipide on the glycosaminoglycan content of the ulcerated rat stomach
D U Song, M H Ryu, K O Chay, et al.
Acta Diabetologica
|
February 6, 2002
Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea
H J Lee, C W Ahn, S J Kim, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
August 10, 2021
A therapeutic intervention for Alzheimer's disease using ginsenoside Rg3: its role in M2 microglial activation and non-amyloidogenesis
J W Ahn, S K Jang, B R Jo, et al.
Diabetes Research and Clinical Practice
|
November 27, 2004
An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea
D M Kim, C W Ahn, J S Park, et al.
Anticancer Research
|
November 1, 2007
Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells
Hee J Chang, Mi H Kim, Min K Baek, et al.
International Journal of Oncology
|
October 4, 2006
Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2
Jung S Park, Mi H Kim, Hee J Chang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 23, 2009
Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone
S E Park, E S Kang, D H Kim, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 29, 2002
Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients
C W Ahn, H S Kim, J H Nam, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 274) with videos related to
Sort By:
Page
of 28
Oncology Reports
|
November 21, 2008
EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells
Min K Baek, Mi H Kim, Hee J Jang, et al.
International Journal of Obesity (2005)
|
April 17, 2008
Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase
E-H Jang, J-S Moon, J H Ko, et al.
Fundamental & Clinical Pharmacology
|
October 30, 1998
Effect of rebamipide on the glycosaminoglycan content of the ulcerated rat stomach
D U Song, M H Ryu, K O Chay, et al.
Acta Diabetologica
|
February 6, 2002
Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea
H J Lee, C W Ahn, S J Kim, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
August 10, 2021
A therapeutic intervention for Alzheimer's disease using ginsenoside Rg3: its role in M2 microglial activation and non-amyloidogenesis
J W Ahn, S K Jang, B R Jo, et al.
Diabetes Research and Clinical Practice
|
November 27, 2004
An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea
D M Kim, C W Ahn, J S Park, et al.
Anticancer Research
|
November 1, 2007
Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells
Hee J Chang, Mi H Kim, Min K Baek, et al.
International Journal of Oncology
|
October 4, 2006
Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2
Jung S Park, Mi H Kim, Hee J Chang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 23, 2009
Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone
S E Park, E S Kang, D H Kim, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 29, 2002
Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients
C W Ahn, H S Kim, J H Nam, et al.
Page
of 28